BioSpace News Archive

Lupin Pharmaceuticals Inc., (Lupin), and Exeltis USA Inc. announced a promotional agreement for Exeltis to promote SOLOSEC® along with Exeltis’ existing line of Women’s Health products, further enhancing value to OBGYNs and their patients.

Today, Maxim Biomedical (MaximBio), announced a comprehensive Marketing and Distribution Agreement with Thomas Scientific for the ClearDetectTM COVID-19 Antigen Home Test (ClearDetectTM) which received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration on January 19, 2022.

The Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer, has hired nonprofit finance and business strategist, Anat Kendal, as its Chief Financial Officer (CFO). The role reports directly to Julie Fleshman, JD, MBA, president and CEO of PanCAN and Kendal’s appointment is effective immediately.

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, is pleased to offer for the second time two lung cancer research award programs to support early-stage lung cancer researchers from underrepresented populations in the biomedical research workforce.

23andMe Holding Co., a leading consumer genetics and research company, announced that it will report financial results for the fiscal year 2022 third quarter after the market closes on Thursday, February 10, 2022.

Peregrine Market Access, a leading life science commercialization partner, has been selected by Nonagen Bioscience to become its contract commercialization organization for Oncuria™, a breakthrough bladder cancer diagnostic test that is being developed to aid in detection, therapy choice, and disease monitoring.

GT Molecular, a company providing multiplexed, ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels, has announced the upcoming release of its sensitive PCR tests to monitor the coronavirus Omicron variant, B.1.1.529.

Oxitec Ltd, the leading developer of biological solutions to control pests that transmit disease, destroy crops and harm livestock, announced the publication of early results heralding a new, transformative crop protection solution for the sustainable management of one of the world’s most devastating crop pests.

Clinical research leaders IACT Health, LMC Manna Research and True North Clinical Research — which joined forces last month — today proudly announced their new name is Centricity Research.

NeuroPace, Inc., a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, announced it will report financial results for the fourth quarter and full year of 2021 after market close on Thursday, March 10, 2022.